Seaport adds Loebel as CMO, Gladstein as general counsel

Neuropsychiatric medicines play Seaport Therapeutics Inc. hired Antony Loebel as CMO and president of clinical development, and Lana Gladstein as general counsel. Loebel was president and CEO of Sunovion Pharmaceuticals Inc. and Gladstein joins from Aprinoia Therapeutics Inc. Seaport launched in April with a $100 million series A round from PureTech Health plc (LSE:PRTC; NASDAQ:PRTC), Arch Venture Partners, Sofinnova Investments and Third Rock Ventures and members of the team behind recently acquired Karuna Therapeutics Inc.

Vaccines company SpyBiotech Ltd. hired Keith Dewedoff as CFO. Dewedoff is a CFO and adviser for Danforth Avisors, before which he was CFO of Kaizen Bioscience and Ceptur Therapeutics Inc. ...